| Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy P Zhao, Y Wang, X Kang, A Wu, W Yin, Y Tang, J Wang, M Zhang, Y Duan, ... Chemical science 9 (10), 2674-2689, 2018 | 213 | 2018 |
| Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy X Kang, H Wang, H Peng, B Chen, W Zhang, A Wu, Q Xu, Y Huang Acta Pharmacologica Sinica 38 (6), 885-896, 2017 | 97 | 2017 |
| Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery Z Zheng, J Zhang, J Jiang, Y He, W Zhang, X Mo, X Kang, Q Xu, B Wang, ... Journal for immunotherapy of cancer 8 (2), 2020 | 83 | 2020 |
| Remodeling Tumor‐Associated Macrophages and Neovascularization Overcomes EGFRT790M‐Associated Drug Resistance by PD‐L1 Nanobody‐Mediated … W Yin, X Yu, X Kang, Y Zhao, P Zhao, H Jin, X Fu, Y Wan, C Peng, ... Small 14 (47), 1802372, 2018 | 69 | 2018 |
| Liposomal codelivery of doxorubicin and andrographolide inhibits breast cancer growth and metastasis X Kang, Z Zheng, Z Liu, H Wang, Y Zhao, W Zhang, M Shi, Y He, Y Cao, ... Molecular pharmaceutics 15 (4), 1618-1626, 2018 | 59 | 2018 |
| BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFRT790M mutation W Yin, Y Zhao, X Kang, P Zhao, X Fu, X Mo, Y Wan, Y Huang Theranostics 10 (14), 6122, 2020 | 55 | 2020 |
| Antiglioma via regulating oxidative stress and remodeling tumor-associated macrophage using lactoferrin-mediated biomimetic codelivery of simvastatin/fenretinide X Mo, Z Zheng, Y He, H Zhong, X Kang, M Shi, T Liu, Z Jiao, Y Huang Journal of controlled release 287, 12-23, 2018 | 54 | 2018 |
| A mannosylated PEI–CPP hybrid for TRAIL gene targeting delivery for colorectal cancer therapy Z Pan, X Kang, Y Zeng, W Zhang, H Peng, J Wang, W Huang, H Wang, ... Polymer Chemistry 8 (35), 5275-5285, 2017 | 35 | 2017 |
| Nano-structural effects on gene transfection: large, botryoid-shaped nanoparticles enhance DNA delivery via macropinocytosis and effective dissociation W Zhang, X Kang, B Yuan, H Wang, T Zhang, M Shi, Z Zheng, Y Zhang, ... Theranostics 9 (6), 1580, 2019 | 25 | 2019 |
| Near-infrared light triggered activation of pro-drug combination cancer therapy and induction of immunogenic cell death X Kang, Y Cai, Q Wang, C Wang, W Chen, W Yang, A Suryawanshi, ... International journal of pharmaceutics 607, 120972, 2021 | 21 | 2021 |
| Diethyldithiocarbamate copper nanoparticle overcomes resistance in cancer therapy without inhibiting P-glycoprotein X Kang, J Wang, CH Huang, FS Wibowo, R Amin, P Chen, F Li Nanomedicine: Nanotechnology, Biology and Medicine 47, 102620, 2023 | 15 | 2023 |
| Neuronal miR-29a protects from obesity in adult mice Y Ma, N Murgia, Y Liu, Z Li, C Sirakawin, R Konovalov, N Kovzel, Y Xu, ... Molecular Metabolism 61, 101507, 2022 | 15 | 2022 |
| Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems X Kang, S Jadhav, M Annaji, CH Huang, R Amin, J Shen, CR Ashby Jr, ... Pharmaceutics 15 (6), 1567, 2023 | 8 | 2023 |
| Targeting β-catenin using XAV939 nanoparticle promotes immunogenic cell death and suppresses conjunctival melanoma progression F Antony, X Kang, C Pundkar, C Wang, A Mishra, P Chen, RJ Babu, ... International Journal of Pharmaceutics 640, 123043, 2023 | 4 | 2023 |
| Targeting Wnt/β-catenin signaling using XAV939 nanoparticles in tumor microenvironment-conditioned macrophages promote immunogenicity C Pundkar, F Antony, X Kang, A Mishra, RJ Babu, P Chen, F Li, ... Heliyon 9 (6), 2023 | 3 | 2023 |
| 3D-Printed Capsaicin-Loaded Injectable Implants for Targeted Delivery in Obese Patients M Annaji, N Mita, J Heard, X Kang, I Poudel, O Fasina, P Baskaran, ... AAPS PharmSciTech 24 (7), 200, 2023 | 1 | 2023 |
| Liposomal DQ in Combination with Copper Inhibits ARID1A Mutant Ovarian Cancer Growth X Kang, Q Wang, S Wu, C Wang, M Annaji, CH Huang, J Shen, P Chen, ... Biomolecules 13 (5), 744, 2023 | 1 | 2023 |
| Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress S Cheng, H Wang, X Kang, H Zhang Pharmaceutics 16 (2), 251, 2024 | | 2024 |
| Long-Acting Drug Delivery Technologies for Meloxicam as a Pain Medicine M Annaji, N Mita, J Heard, X Kang, I Poudel, SHS Boddu, AK Tiwari, ... Critical Reviews™ in Therapeutic Drug Carrier Systems 41 (5), 2024 | | 2024 |
| Tumor-Associated Macrophage Targeting of Nanomedicines in Cancer Therapy X Kang, Y Huang, H Wang, S Jadhav, Z Yue, AK Tiwari, RJ Babu Pharmaceutics 16 (1), 61, 2023 | | 2023 |
Yongzhuo Huang (黄永焯)Shanghai Institute of Materia Medica, Chinese Academy of SciencesVerified email at simm.ac.cn
